首页|卡孕栓联合宫缩素预防产后出血的112例效果分析

卡孕栓联合宫缩素预防产后出血的112例效果分析

扫码查看
目的:探讨分析卡孕栓联合宫缩素预防产后出血的临床疗效。方法:回顾性分析2010年8月至2013年3月间于我院进行正常分娩的224例产妇的临床记录资料。结果:治疗组的产后出血率为2.68%,明显低于于对照组的9.82%;具有显著性差异(P<0.05);治疗组的第三产程时间、产后2h出血量以及产后24h出血量均明显低于对照组,具有显著性差异(P<0.01);两组的收缩压、舒张压和治疗前相比,均无明显变化(P>0.05);用药后两组的收缩压、舒张压相比,也无显著性差异(P>0.05);治疗组的不良反应发生率为8.04%,和对照组的6.25%相比;无显著性差异(P>0.05)。结论:卡孕栓联合宫缩素预防产后出血的临床疗效显著,值得临床推广应用。
Prevention value of carboprost suppositories combined oxytocin for 112 cases of postpartum hemorrhage
Objective: To investigate prevention value of carboprost suppositories combined oxytocin for postpartum hemorrhage. Methods: Clinical data of 224 cases of parturient women in our hospital from August 2010 to March 2013 were reviewed. Results: The postpartum hemorrhage rate of treatment group(2.68%) was significantly lower than that of control group(9.82%),with a significant difference (P <0.05). The third stage of labor , postpartum hemorrhage 2h and 24h postpartum hemorrhage of treatment group were significantly lower than that of the control group,(P<0.01). After treatment , the systolic blood pressure and diastolic blood pressure between two groups had no significant difference(P>0.05).The adverse reactions rate of treatment group( 8.04%) was not significant different with that of the control group (6.25%)(P> 0.05).Conclusion:The carboprost suppositories combined oxytocin for postpartum hemorrhage have significant clinical efficacy.

carboprost suppositoriesoxytocinpostpartum hemorrhage

熊艳、张建、刘琴、董守金

展开 >

腾冲县妇幼保健院妇产科 云南保山 679100

腾冲县人民医院妇产科 云南保山 679100

卡孕栓 宫缩素 产后出血

2014

中外健康文摘
中国中医药报社

中外健康文摘

影响因子:0.016
ISSN:1672-5085
年,卷(期):2014.(3)
  • 1
  • 8